Company: MDCXW
Filing Date: 2025-09-02
Form Type: 8-K
Source: 0001062993-25-015149
Chunk: 3

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-02
Form: 8-K
Item: Item 3.02
Chunk 3
---
 any committees of the Board at this time.

Mr. Mahaffy will receive $60,000 in annual cash compensation for his service on the Board and would be entitled to an additional $10,000 in annual cash compensation if he were appointed to serve as chair of any committee of the Board. In connection with his appointment, Mr. Mahaffy also received a grant of 25,000 stock options, which stock options will expire in five years, have an exercise price of $1.94, and will vest in equal quarterly instalments over the twelve months immediately following August 29, 2025.

There are no arrangements or understandings between Mr. Mahaffy and any other person pursuant to which Mr. Mahaffy was appointed as a director, there are no family relationships between Mr. Mahaffy and any director or other officer of the Company, and there are no transactions in which the Company is a party and in which Mr. Mahaffy has a material interest subject to disclosure under Item 404(a) of Regulation S-K.

Item 8.01. Other Events.